menu search

Gilead sciences told by fda to pause patient enrollment in leukemia drug trials

Gilead Sciences, Inc. (NASDAQ:GILD) said the Food and Drug Administration (FDA) has put a clinical hold on its ...

August 21, 2023, 10:41 am

Us fda puts gilead sciences blood cancer drug studies on hold

Gilead Sciences said on Monday the U.S. Food and Drug Administration had placed a partial clinical hold on initiating new patients in the U.S. ...

August 21, 2023, 8:52 am

Gilead says fda hits pause on study of leukemia treatment

Gilead Sciences Inc. GILD, -0.81% said Monday that the U.S. Food and Drug Administration has put a partial clinical hold on U.S. ...

August 21, 2023, 8:47 am

Urogen pharma (urgn) stock surges 89% in a month: here's why

This jump in UroGen's (URGN) stock price is attributable to positive data from two late-stage studies o...

August 18, 2023, 2:49 pm

Gbp/usd outlook: cable eases on downbeat uk data, but needs to clear key supports to signal reversal

Daily studies are bearishly aligned as momentum indicator remains in the negative territory and RSI is ...

August 18, 2023, 8:29 am

Xrp/usd booking losses; further downside possible

Chart studies reveal that XRP/USD shows room for further weakness toward weekly support. The post XRP/U...

August 17, 2023, 6:13 pm

Us dollar index: daily trendline resistance breach ahead of fomc minutes

Direct from the Research Desk, chart studies are showing signs that dollar bulls may remain on the offe...

August 16, 2023, 4:41 pm

Aud/usd outlook: larger bears may take a breather as daily studies are oversold

Daily studies are firmly bearish and along with negative fundamentals, point to mild correction before ...

August 16, 2023, 10:59 am

Power nickel says investment will fund feasibility program as nisk project in quebec

Power Nickel Inc (TSX-V:PNPN) told investors it has entered into an agreement with CVMR Corporation to coordinate the production of advanced bench sc...

August 16, 2023, 8:16 am

Spexis announces usd $2.5 million capital commitment to support the upcoming phase 3 colifin® studies

Ad hoc announcement pursuant to Art. 53 LR ALLSCHWIL, Switzerland, Aug. 14, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharm...

August 15, 2023, 5:15 am

Nektar (nktr) stock surges 75% in a week: here's why

Nektar's (NKTR) shares rally almost 75% in a week on corrected efficacy data for rezpeg studies, earlie...

August 14, 2023, 1:09 pm

Eur/usd outlook: near-term action to remain sideways while 100dma holds

Near-term action was held again by 100DMA (1.0930), suggesting that bears may pause here, keeping the pair in extended sideways mode of past two weeks...

August 14, 2023, 9:14 am

The prognosis for pds biotechnology

PDS Biotechnology Corporation has had a volatile stock performance in recent years. The company has made slow and steady progress advancing its pipeli...

August 13, 2023, 5:30 am

General dynamics (gd) wins deal to aid virginia class submarines

General Dynamics (GD) is set to provide lead yard support and development studies and design efforts re...

August 11, 2023, 12:17 pm

Akero therapeutics reports second quarter 2023 financial results and provides business update

— Positive Results from Phase 2b SYMMETRY Cohort D, an expansion cohort of Type 2 diabetic, pre-cirrhotic NASH patients treated with EFX or placebo ...

August 11, 2023, 10:00 am

Nvidia stock: 6 reasons to think twice before buying

Nvidia Corporation is now the 6th largest company in the world by market value, surpassing Tesla, Meta Platforms, and Taiwan Semiconductor Manufacturi...

August 10, 2023, 3:13 pm

New community partnership model boosts participant inclusion into hiv cure-directed research

Wistar scientists propose more equitable, collaborative standard to advance HIV cure-directed research PHILADELPHIA, PA, Aug. 08, 2023 (GLOBE NEWSWIRE...

August 8, 2023, 5:11 pm

Nektar rallies after releasing new data for rezpeg after eli lilly got it wrong

Nektar Therapeutics (NASDAQ:NKTR) shares rallied more than 15% in Monday pre-market trading after the company released new efficacy data from phase 1...

August 7, 2023, 8:10 am

Editas' (edit) q2 earnings beat, sales miss, pipeline in focus

Editas (EDIT) reports mixed second-quarter 2023 results. EDIT-301 studies remain on track to provide up...

August 3, 2023, 1:30 pm

Quoin pharmaceuticals provides corporate update and announces second quarter 2023 financial results

Company reports positive clinical data for first subject to complete testing in ongoing open-label Netherton Syndrome study Subject’s skin was asses...

August 2, 2023, 8:45 pm


Search within

Pages Search Results: